f
t
i
x
Menu
Toggle navigation
Home
Support
Find a Support Group
Join a Phone Support Group
Join an Online Prostate Cancer Support Community
“A Forum for Her” Support Group for Female Caregivers
A Prostate Cancer Forum for Gay Men and Their Partners
One on One Support
Helpline
Spouses/Partner/Family
Financial Assistance
Additional Resources
Prostate Cancer Care Team Hub
GU Connect Programs for GU Professionals
SEA Stories
Start a Support Group
Volunteer to Help
Donate
Virtual UsTOO Support Group Meetings
Education
Read the Hot SHEET
News You Can Use
Videos
Facts and Stats
Why You Should Care
Risk Factors
Between the Sheets…
Progress on Prostate Cancer Research
Military Veterans
My Prostate Cancer Roadmap
Read Educational Materials
Request Printed Materials
Physicians’ Perspective
Glossary
Donate
Diagnosis and Treatment
Detection
Genetics/Genomics
Newly Diagnosed
Treatment Options
Chemotherapy
Drugs
Side Effects
Anxiety and Depression
Sexual Health and Intimacy
Incontinence
Recurring Prostate Cancer
Advanced Prostate Cancer
Clinical Trials
NCCN Guidelines for Patients
About Us TOO
Mission/Vision
The Value of Us TOO
Leadership and Staff
Support Group Leader Resources
501c(3) Status
Us TOO Reports
History of Us TOO
Us TOO Media Kit
Subscribe
Contact Us
Donate
News and Events
SEA Blue Prostate Walk/Run
Recent Emails
Outreach and News
Educational Events/Calendar
Donate
Hot Sheets 2009- UsToo Internationl
Subscribe to Get Prostate Cancer News
Fill out my Wufoo form!
Home
Support
Find a Support Group
Join a Phone Support Group
Join an Online Prostate Cancer Support Community
“A Forum for Her” Support Group for Female Caregivers
A Prostate Cancer Forum for Gay Men and Their Partners
One on One Support
Helpline
Spouses/Partner/Family
Financial Assistance
Additional Resources
Prostate Cancer Care Team Hub
GU Connect Programs for GU Professionals
SEA Stories
Start a Support Group
Volunteer to Help
Donate
Virtual UsTOO Support Group Meetings
Education
Read the Hot SHEET
News You Can Use
Videos
Facts and Stats
Why You Should Care
Risk Factors
Between the Sheets…
Progress on Prostate Cancer Research
Military Veterans
My Prostate Cancer Roadmap
Read Educational Materials
Request Printed Materials
Physicians’ Perspective
Glossary
Donate
Diagnosis and Treatment
Detection
Genetics/Genomics
Newly Diagnosed
Treatment Options
Chemotherapy
Drugs
Side Effects
Anxiety and Depression
Sexual Health and Intimacy
Incontinence
Recurring Prostate Cancer
Advanced Prostate Cancer
Clinical Trials
NCCN Guidelines for Patients
About Us TOO
Mission/Vision
The Value of Us TOO
Leadership and Staff
Support Group Leader Resources
501c(3) Status
Us TOO Reports
History of Us TOO
Us TOO Media Kit
Subscribe
Contact Us
Donate
News and Events
SEA Blue Prostate Walk/Run
Recent Emails
Outreach and News
Educational Events/Calendar
Donate
Subscribe
Fill out my Wufoo form!
HotSheets by Year
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
HotSheets 2009
January
February
March
April
May
June
July
August
September
October
November
December
January
|
Newsletter
|
Cover Letter
Diagnoses of Cancer Decline in the US
Cleveland Clinic Unveils ‘Top 10’ Medical Innovations for 2009
Antidiabetic Drugs Linked to Lower Risk of Prostate Cancer
Index of Articles Appearing in the 2008 Us TOO HotSheets
Doc Moyad’s “What Works and What Is Worthless Column”— The JUPITER trial
PSA Doubling Time and Time to Biochemical Failure May Predict Prostate Cancer-Specific Mortality
Read more..
February
|
Newsletter
|
Cover Letter
Us TOO Names 2009 Board Officers & Members
FDA Approves Ferring Pharmaceuticals’ Degarelix (generic name) for Advanced Prostate Cancer
Geography’s Role in Medicare Cancer Coverage
Low-Income Men More Often Diagnosed with Advanced Prostate Cancer
FDA Commissioner to Step Down
Us TOO Pleasanton, California Chapter Honors Memory of Bill Stone
The Doctor’s Note—Dr. Gerald Chodak
Read more..
March
|
Newsletter
|
Cover Letter
Medicare Widens Drugs It Accepts for Cancer
Experts Urge Prostate Cancer “Man-o-Gram’
Prostate Cancer and Neglect of Other Illnesses
Thalidomide for the Treatment of Biochemically Recurrent Prostate Cancer
Adjuvant Radiotherapy Improves Survival after Radical Prostatectomy
Donated Items Sought for June Online Auction
Family History of Prostate Cancer Does Not Affect Treatment Outcomes
Read more..
April
|
Newsletter
|
Cover Letter
Stop PSA Screening in Men Over 75 — But Only Those With Low PSA, Says New Study
Researchers Identify Biomarker for Fatal Prostate Cancer
Costs Force Cancer Survivors to Pass on Health Care
Molecule’s Prevalence May Aid in Deciding Whether to Treat Prostate Cancer
GTx Announces Phase III Clinical Development of Toremifene 20 mg on Course Following Safety Review
Preventing Prostate Cancer: Good Nutrition May Be Key
Personalized Calculator for Future Prostate Cancer Risk
Read more..
May
|
Newsletter
|
Cover Letter
What to Make of the Prostate Cancer Screening Studies
A Joint Statement from America’s Prostate Cancer Advocacy, Education and Support Organizations
Leading US-Based Prostate Cancer Organizations Develop Joint Policy Agenda
PSA Has Higher Predictive Ability in Black Men than in White Men
Highlights from the 2009 ASCO GU Cancers Symposium
Selected Men with Low-Risk Prostate Cancer Have Good Clinical Outcomes without Immediate Treatment
The Doctor’s Note — Dr. Gerald Chodak
Read more..
June
|
Newsletter
|
Cover Letter
Urologists Support Baseline PSA Test at Age 40
Provenge® Significantly Improves Survival
Living and Loving with Prostate Cancer
Us TOO Seeks Board Member Applications
Statins May Protect Prostate Health
Race May Not Be Key in Cancer Disparities
Gene Variant Linked to Aggressive Cancers
Agent Orange & Rapidly Recurrent Cancer
NCI’s Plan to Accelerate Cancer Research
Read more..
July
|
Newsletter
|
Cover Letter
Signposts Brochure Now Available
Young Men with Advanced Cancer & Prognosis
False Positives in Screening Reduced by New Test
Predicting Prostate Cancer Recurrence
Combidex® & Lymph Node Metastasis
Us TOO Seeks Board Member Applications
Prostate Cancer Yet Another Worry for Women
Future of Cancer Incidence in the United States: Burdens Upon an Aging, Changing Nation
Read more..
August
|
Newsletter
|
Cover Letter
New Urinary Continence Brochure Available
Prostate Cancer Patients Should Not Take Selenium
Test Improves Prediction of Disease Course
Predicting the Return of Prostate Cancer
Prostate Cancer Screening: A Question of Common Sense — Dr. Louis Denis, Us TOO Belgium
Men with Post-RP pT3 Disease & An Undetectable PSA Benefit from Adjuvant Radiation Therapy
Prostate Shrinkage May Reveal High-Grade Cancer
Read more..
September
|
Newsletter
|
Cover Letter
Special Burning Issues Supplement: Identifying Clinically Significant Prostate Cancers
PCAM Activities
Study Finds Acceptable Levels of Anxiety in Men Living with Early, Untreated Prostate Cancer
Heavy Drinking Boosts Prostate Cancer Risk
Prostatectomy May Not Always Be Necessary
Awareness of Prostate Cancer in the General Public
Some Cancer Rates Higher in the Military
HIFU in the Treatment of Primary Prostate Cancer
Read more..
October
|
Newsletter
|
Cover Letter
Denosumab Prevents Fractures in Men with Non-Metastatic Prostate Cancer Receiving ADT
Coronary Artery Disease Risks with ADT
FDA Issues Final Rules to Help Patients Gain Access to Investigational Drugs
‘Watchful Waiting’ Is a Viable Option for Prostate Cancer Patients with Low-Risk Tumors
PET/CT Scans May Help Detect Recurring Prostate Cancer Earlier
Robotic Surgery May Improve Functional Outcome
Larry King Live Video Discusses Early Detection of Prostate Cancer Using the PSA Test
Doc Moyad’s “What Works and What Is Worthless Column”— Coenzyme Q10
Read more..
November
|
Newsletter
|
Cover Letter
Link Found Between Common Sexual Infection and Risk of Aggressive Prostate Cancer
Every Mustache Makes a Difference
New Web-Based Us TOO Prostate Cancer Support Community
Soy Pills Fail to Prevent Bone Loss
Men Diagnosed with Prostate Cancer in Recent Years Have Better Survival Outcomes
Getting Closer to the Origins of Prostate Cancer
Protein Tied with Aggressive Prostate Cancer
5th Annual Chicago SEA Blue Prostate Cancer Walk
Doc Moyad’s “What Works and What Is Worthless Column”— For BPH, Drugs Are Better than Herbs
Read more..
December
|
Newsletter
|
Cover Letter
Doc Moyad’s “No Bogus Science” Column—Why I Donate to Us TOO International
AUA Releases Statement Clarifying Prostate Cancer Testing Recommendations
Dendreon Completes Submission of Biologics License Application for PROVENGE®
Questions on Breast & Prostate Cancer Screening
American Cancer Society Stands by its Screening Guidelines; Mammograms for Women Encouraged
FDA Says No to Amgen Bone Drug
Radical Prostatectomy Finding in Patients Who Fail Active Surveillance for Prostate Cancer
Clinicians Map Group at High Risk for Aggressive “Hidden” Prostate Cancer
Read more..
×
Log In
Email
(*)
Password
(*)